These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 25485515)

  • 1. Important issues in determining the cut-offs for liver fibrosis index.
    Sertoglu E; Kayadibi H; Uyanik M
    J Clin Gastroenterol; 2015 Jan; 49(1):90-1. PubMed ID: 25485515
    [No Abstract]   [Full Text] [Related]  

  • 2. Noninvasive markers of liver fibrosis in Latin America and Mexico.
    Uribe M; Gutiérrez-Grobe Y; Kobashi-Margáin RA; Méndez-Sánchez N
    Ann Hepatol; 2010; 9 Suppl():43-8. PubMed ID: 20713995
    [No Abstract]   [Full Text] [Related]  

  • 3. How to assess liver fibrosis in chronic hepatitis C: serum markers or transient elastography vs. liver biopsy?
    Castera L; Bedossa P
    Liver Int; 2011 Jan; 31 Suppl 1():13-7. PubMed ID: 21205132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of nine blood tests and transient elastography for liver fibrosis in chronic hepatitis C: the ANRS HCEP-23 study.
    Zarski JP; Sturm N; Guechot J; Paris A; Zafrani ES; Asselah T; Boisson RC; Bosson JL; Guyader D; Renversez JC; Bronowicki JP; Gelineau MC; Tran A; Trocme C; De Ledinghen V; Lasnier E; Poujol-Robert A; Ziegler F; Bourliere M; Voitot H; Larrey D; Rosenthal-Allieri MA; Fouchard Hubert I; Bailly F; Vaubourdolle M;
    J Hepatol; 2012 Jan; 56(1):55-62. PubMed ID: 21781944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contemporary assessment of hepatic fibrosis.
    Bonder A; Tapper EB; Afdhal NH
    Clin Liver Dis; 2015 Feb; 19(1):123-34. PubMed ID: 25454300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determining cut-off points for enhanced liver fibrosis panel.
    Fernandes FF; de Mello Perez R; Ferraz ML
    J Clin Gastroenterol; 2015 Jan; 49(1):91-2. PubMed ID: 25144901
    [No Abstract]   [Full Text] [Related]  

  • 7. Noninvasive methods to assess liver disease in patients with hepatitis B or C.
    Castera L
    Gastroenterology; 2012 May; 142(6):1293-1302.e4. PubMed ID: 22537436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-invasive assessment of liver fibrosis: time to move from cross-sectional studies to longitudinal ones.
    Kim SU; Han KH; Ahn SH
    J Gastroenterol Hepatol; 2010 Sep; 25(9):1472-3. PubMed ID: 20796140
    [No Abstract]   [Full Text] [Related]  

  • 9. Prospective comparison of two algorithms combining non-invasive methods for staging liver fibrosis in chronic hepatitis C.
    Castéra L; Sebastiani G; Le Bail B; de Lédinghen V; Couzigou P; Alberti A
    J Hepatol; 2010 Feb; 52(2):191-8. PubMed ID: 20006397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How far is noninvasive assessment of liver fibrosis from replacing liver biopsy in hepatitis C?
    Sebastiani G; Alberti A
    J Viral Hepat; 2012 Jan; 19 Suppl 1():18-32. PubMed ID: 22233410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Limited reliability of five non-invasive biomarkers in predicting hepatic fibrosis in chronic HCV mono-infected patients opposed to METAVIR scoring.
    Elesawy BH; Abd El Hafez A; Dorgham LS; El-Askary A
    Pathol Res Pract; 2014 Dec; 210(12):922-8. PubMed ID: 25123964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-invasive evaluation of liver fibrosis in chronic hepatitis C.
    Trifan A; Cojocariu C; Sfarti C; Singeap AM; Stanciu C
    Rev Med Chir Soc Med Nat Iasi; 2012; 116(1):135-8. PubMed ID: 23077885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is there any relationship between mean platelet volume and liver fibrosis severity in chronic hepatitis C?
    Beyan C
    Clin Res Hepatol Gastroenterol; 2012 Aug; 36(4):e81-2; author reply e82. PubMed ID: 22766149
    [No Abstract]   [Full Text] [Related]  

  • 14. Liver fibrosis in patients with chronic hepatitis C and persistently normal liver enzymes: influence of HIV infection.
    Martin-Carbonero L; de Ledinghen V; Moreno A; Maida I; Foucher J; Barreiro P; Romero M; Satta G; Garcia-Samaniego J; Gonzalez-Lahoz J; Soriano V
    J Viral Hepat; 2009 Nov; 16(11):790-5. PubMed ID: 19413693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual cut-off transient elastography to assess liver fibrosis in chronic hepatitis B: a cohort study with internal validation.
    Viganò M; Paggi S; Lampertico P; Fraquelli M; Massironi S; Ronchi G; Rigamonti C; Conte D; Colombo M
    Aliment Pharmacol Ther; 2011 Aug; 34(3):353-62. PubMed ID: 21631559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-invasive evaluation of the fibrosis stage in chronic hepatitis C: a comparative analysis of nine scoring methods.
    Ladero JM; Delkader J; Ortega L; Fernández C; Devesa MJ; López-Alonso G; Mayol J; Cuenca F; Suárez A; Taxonera C; Díaz-Rubio M
    Scand J Gastroenterol; 2010; 45(1):51-9. PubMed ID: 20030577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 13C-methacetin-breath test compared to also noninvasive biochemical blood tests in predicting hepatic fibrosis and cirrhosis in chronic hepatitis C.
    Dinesen L; Caspary WF; Chapman RW; Dietrich CF; Sarrazin C; Braden B
    Dig Liver Dis; 2008 Sep; 40(9):743-8. PubMed ID: 18339592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibroscan and FibroTest/FibroMax to assess liver fibrosis/cirrhosis in patients with chronic HBV and HCV infection in Georgia.
    Dolmazashvili E; Zhamutashvili M; Svanidze M; Nizharadze N; Abutidze A
    Georgian Med News; 2008 Dec; (165):83-7. PubMed ID: 19124923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The usefulness of measuring liver stiffness by transient elastography for assessing hepatic fibrosis in patients with various chronic liver diseases.
    Tamano M; Kojima K; Akima T; Murohisa T; Hashimoto T; Uetake C; Sugaya T; Nakano M; Hiraishi H; Yoneda M
    Hepatogastroenterology; 2012 May; 59(115):826-30. PubMed ID: 22469726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative assessment of liver fibrosis by computerized morphometry in naïve patients with chronic hepatitis B and C.
    Sturm N; Marlu A; Arvers P; Zarski JP; Leroy V
    Liver Int; 2013 Mar; 33(3):428-38. PubMed ID: 23402612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.